Fact check · Version 1 · Sources checked
“Semax treats stroke, migraine, or severe facial pain.”
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Not established
The reviewed evidence does not establish this statement. This does not prove it can never be true.
FDA staff found insufficient evidence of effectiveness for cerebral ischemia, migraine, or trigeminal neuralgia. The two stroke studies listed here have important design and comparison limits.
- What this answer is based on
- No reliable study in people shows the health outcome in this statement.
- Limits of this answer
- The uses reviewed by FDA in 2026; this does not assess every possible research question. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- What a study measured about people's health, symptoms, or ability to function.
Sources for this fact check
Show 3 sources
01FDA evaluation of Semax-related bulk drug substancesU.S. Food and Drug Administration · FDA review · 202602The efficacy of Semax in the treatment of patients at different stages of ischemic strokePubMed · Human clinical study · 201803Effectiveness of Semax in acute period of hemispheric ischemic strokePubMed · Human clinical study · 1997
- Sources checked by
- Site editor · Editorial review